Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

[Systemic treatment of ocular cicatricial pemphigoid].

Juri MC, Fernández Romero DS, Devoto MH, Georgiett D, Zárate JO, Malbrán A.

Medicina (B Aires). 2012;72(2):103-8. Spanish.

2.

The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.

Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS.

Ophthalmology. 2002 Jan;109(1):111-8.

PMID:
11772589
4.

Systemic chemotherapy for ocular cicatricial pemphigoid.

Tauber J, Sainz de la Maza M, Foster CS.

Cornea. 1991 May;10(3):185-95.

PMID:
2055022
5.

[Cicatricial pemphigoid: management in stomatology].

Agbo-Godeau S, de Lima Soares P, Szpirglas H.

Rev Stomatol Chir Maxillofac. 2004 Sep;105(4):206-10. French.

PMID:
15510070
6.

Current medical treatment of ocular mucous membrane pemphigoid.

Sobolewska B, Deuter C, Zierhut M.

Ocul Surf. 2013 Oct;11(4):259-66. doi: 10.1016/j.jtos.2013.02.003. Epub 2013 Jul 9. Review.

PMID:
24112229
7.

[Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications].

Messmer EM, Hintschich CR, Partscht K, Messer G, Kampik A.

Ophthalmologe. 2000 Feb;97(2):113-20. German.

PMID:
10734737
8.

Methotrexate therapy for ocular cicatricial pemphigoid.

McCluskey P, Chang JH, Singh R, Wakefield D.

Ophthalmology. 2004 Apr;111(4):796-801.

PMID:
15051215
10.

Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.

Sami N, Letko E, Androudi S, Daoud Y, Foster CS, Ahmed AR.

Ophthalmology. 2004 Jul;111(7):1380-2.

PMID:
15234140
11.

[Diagnostics and pharmacological treatment of ocular cicatrical pemphigoid].

Brydak-Godowska J, Moneta-Wielgoś J, Pauk-Domańska M, Dróbecka-Brydak E, Samsel A, Kecik M, Kowalewski C, Mackiewicz W, Kecik D.

Klin Oczna. 2005;107(10-12):725-7. Review. Polish.

PMID:
16619831
12.

Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid.

Neumann R, Tauber J, Foster CS.

Ophthalmology. 1991 Jun;98(6):858-62.

PMID:
1866137
13.

Ocular cicatricial pemphigoid, keratomycosis, and intravenous immunoglobulin therapy.

Iaccheri B, Roque M, Fiore T, Papadaki T, Mathew B, Baltatzis S, Emara B, Tokarewicz AC, Foster CS.

Cornea. 2004 Nov;23(8):819-22.

PMID:
15502484
14.

Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.

Saw VP, Dart JK, Rauz S, Ramsay A, Bunce C, Xing W, Maddison PG, Phillips M.

Ophthalmology. 2008 Feb;115(2):253-261.e1. Epub 2007 Jul 26.

PMID:
17655931
15.

Update on ocular cicatricial pemphigoid and emerging treatments.

Queisi MM, Zein M, Lamba N, Meese H, Foster CS.

Surv Ophthalmol. 2016 May-Jun;61(3):314-7. doi: 10.1016/j.survophthal.2015.12.007. Epub 2015 Dec 19. Review.

PMID:
26708362
17.

Ocular cicatricial pemphigoid.

Tauber J.

Ophthalmology. 2008 Sep;115(9):1639-40; author reply 1640-1. doi: 10.1016/j.ophtha.2008.06.002. No abstract available.

PMID:
18762085
18.

[Ocular Cicatricial Pemphigoid - a Retrospective Study].

Szabó E, Palos M, Skalická P.

Cesk Slov Oftalmol. 2016 Feb;72(1):283-92. Czech.

PMID:
27041284
19.

Progression of disease in ocular cicatricial pemphigoid.

Elder MJ, Bernauer W, Leonard J, Dart JK.

Br J Ophthalmol. 1996 Apr;80(4):292-6.

20.

Dapsone therapy of cicatricial pemphigoid.

Rogers RS 3rd, Mehregan DA.

Semin Dermatol. 1988 Sep;7(3):201-5. Review.

PMID:
3153445

Supplemental Content

Support Center